Background: Effective and safe antiviral treatments are required to refrain the COVID-19.
Objectives: Investigate the efficacy and safety of interferon in the treatment of COVID-19.
Methods: The inclusion criteria were patients who gave their signed consent, with detection confirmed by RT-PCR of SARS-CoV-2, 18 years and older.
Objective: To investigate the effect of alveolar recruitment combined with surfactant administration on children with acute respiratory distress syndrome (ARDS).
Material And Methods: A prospective, randomized, controlled and sequential study was carried out. Group A (16 children) was treated with both the alveolar recruitment manoeuvres (ARM) and the administration of the surfactant every 8 h for 3 days; group B (15) received the usual treatment only.